ClinicalTrials.Veeva

Menu

Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)

Ascensia Diabetes Care logo

Ascensia Diabetes Care

Status

Completed

Conditions

Diabetes

Treatments

Device: Subjects WITH Diabetes Use Karajishi Contour BGMS
Device: Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS

Study type

Interventional

Funder types

Industry

Identifiers

NCT02150109
GCA-2014-002-01

Details and patient eligibility

About

The purpose of this study was to determine if untrained persons with diabetes and without diabetes could operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid blood glucose results.

Enrollment

372 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males and females, 18 years of age and older
  • Able to speak, read, and understand English
  • Willing to complete all study procedures

Exclusion criteria

  • Hemophilia or any other bleeding disorder
  • Pregnancy
  • Physical, visual, or neurological impairments that would make the person unable to perform testing with the BGM
  • Previously participated in a BG monitor study using the Karajishi Contour BGMS (or used a Bayer Contour meter)
  • Work for a medical laboratory, hospital, or other clinical setting that involves training on and clinical use of blood glucose monitors
  • Work for a competitive medical device company, or having an immediate family member who works for such a company
  • A condition which, in the opinion of the investigator or designee, would put the person or study conduct at risk

General enrollment guidelines:

  • Most subjects will be persons with type 1 or type 2 diabetes
  • At least 10% of subjects with diabetes will have type 1 diabetes
  • Approximately 10% of subjects will be persons without diabetes
  • At least 60% of subjects will be younger than age 65

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

372 participants in 2 patient groups

Persons With Diabetes
Experimental group
Description:
Untrained subjects WITH Diabetes use Karajishi Contour BGMS (Blood Glucose Monitoring System).
Treatment:
Device: Subjects WITH Diabetes Use Karajishi Contour BGMS
Persons With and Without Diabetes
Experimental group
Description:
Untrained subjects WITH/WITHOUT Diabetes use Karajishi Contour BGMS (Blood Glucose Monitoring System).
Treatment:
Device: Subjects WITH/WITHOUT Diabetes Use Karajishi Contour BGMS

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems